Bausch Health Companies Inc. (FRA:BVF)

Germany flag Germany · Delayed Price · Currency is EUR
4.777
+0.027 (0.56%)
At close: Feb 20, 2026
Market Cap1.93B -25.6%
Revenue (ttm)8.74B +6.7%
Net Income133.72M
EPS0.36
Shares Outn/a
PE Ratio14.42
Forward PE1.38
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume56
Open4.777
Previous Close4.750
Day's Range4.777 - 4.777
52-Week Range3.986 - 7.000
Betan/a
RSI44.00
Earnings DateFeb 18, 2026

About Bausch Health Companies

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The Intern... [Read more]

Industry Pharmaceutical Preparations
CEO Thomas Appio
Employees 20,300
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol BVF
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements